Fate Therapeutics Inc
FATE
Market Cap$138.71M
Close$
$8.54
605.9% upside
Current Fair Value
605.9% upsideUndervalued by 605.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $138.71 Million |
|---|---|
| Enterprise Value | $181.52 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.64 |
| Beta | 2.33 |
| Outstanding Shares | 118,375,540 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.81 |
|---|---|
| PEG | 3.77 |
| Price to Sales | - |
| Price to Book Ratio | 0.61 |
| Enterprise Value to Revenue | 13.61 |
| Enterprise Value to EBIT | -0.98 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 0.3 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Fate Therapeutics Inc
CEO: William Rastetter